Why Coronavirus Cases Are Falling; New COVID-19 Vaccine Promising : Consider This from NPR After more than 500,000 deaths and nearly a full year, experts say there are a growing number of reasons to be optimistic about the direction of the pandemic. Cases, hospitalizations and deaths have all fallen dramatically in recent weeks.

Among those falling numbers, a vaccine from Johnson & Johnson that may be authorized by the Food and Drug Administration this week. Dr. Ashish Jha of Brown University explains why the shot is just as desirable as already-authorized vaccines from Pzifer and Moderna.

Here's NPR's tool for how to sign up for a COVID-19 vaccination in your state.

The Biden administration has promised to ramp up vaccination efforts even more as soon as Congress authorizes more money to do so. NPR congressional correspondent Kelsey Snell has an update on the $1.9 trillion rescue package speeding through the House.

Additional reporting on the drop in COVID-19 case rates in this episode came from NPR's Allison Aubrey and Will Stone.

In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.

Email us at considerthis@npr.org.
NPR logo

Optimism About Case Rates, Vaccines, And Future Of The Pandemic

  • Download
  • <iframe src="https://www.npr.org/player/embed/970242514/970687708" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Optimism About Case Rates, Vaccines, And Future Of The Pandemic

Optimism About Case Rates, Vaccines, And Future Of The Pandemic

Optimism About Case Rates, Vaccines, And Future Of The Pandemic

  • Download
  • <iframe src="https://www.npr.org/player/embed/970242514/970687708" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Anne Cook sits with her husband, Jack Cook, as he receives his second dose of the Pfizer COVID-19 vaccine during a mass vaccination event in the parking lot of Coors Field on Saturday in Denver, Colo. Michael Ciaglo/Getty Images hide caption

toggle caption
Michael Ciaglo/Getty Images

Anne Cook sits with her husband, Jack Cook, as he receives his second dose of the Pfizer COVID-19 vaccine during a mass vaccination event in the parking lot of Coors Field on Saturday in Denver, Colo.

Michael Ciaglo/Getty Images

After more than 500,000 deaths and nearly a full year, experts say there are a growing number of reasons to be optimistic about the direction of the pandemic. Cases, hospitalizations and deaths have all fallen dramatically in recent weeks.

Among those falling numbers, a vaccine from Johnson & Johnson that may be authorized by the Food and Drug Administration this week. Dr. Ashish Jha of Brown University explains why the shot is just as desirable as already-authorized vaccines from Pzifer and Moderna.

Here's NPR's tool for how to sign up for a COVID-19 vaccination in your state.

The Biden administration has promised to ramp up vaccination efforts even more as soon as Congress authorizes more money to do so. NPR congressional correspondent Kelsey Snell has an update on the $1.9 trillion rescue package speeding through the House.

Additional reporting on the drop in COVID-19 case rates in this episode came from NPR's Allison Aubrey and Will Stone.

In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.

Email us at considerthis@npr.org.

This episode was produced by Lee Hale, Brianna Scott and Brent Baughman. It was edited by Sami Yenigun with help from Scott Hensley and Wynne Davis. Our executive producer is Cara Tallo.